BSEBoard Meeting19 Oct 2026 · 19 Oct 2026, 05:55 pm

Colinz Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/10/2026 ,inter alia, to consider and approve We wish to inform you that pursuant to Regulation 29 and other applicable provisions of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations'), a meeting of the Board of Directors of the Company is scheduled ....

Colinz Laboratories Ltd · 531210

✦ AI SummaryResults

Colinz Laboratories Ltd has informed BSE that a meeting of the Board of Directors is scheduled on 29/10/2026 to consider and approve unaudited financial results for the quarter and half year ended on September 30, 2026.

Analysis Scores

Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact8/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Colinz Laboratories Ltd - 531210 - Board Meeting Intimation for Intimation Of Board Meeting Under Regulation 29 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.

Attachments (1)

📄

846215e9-6a37-4d22-a50f-e487a58bc90f.pdf

pdf

Download →
View document text
Colinz 19e October,2026 The Manager, The BSE Limited Department of Corporate Services 25th Floor, P.J. Towers, Dalal Street Fort, Mumbai - 400 001 Scrip Code:531210 Re: Intimation of Board Meeting under Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Sub.: Fixation of Board Meeting on Thursday,2gth octoberr 2026 Dear Sir/Ma'arfl, We wish to inform you that pursuant to Regulati on 29 and other applicable provisions of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ("Listing RegulationS"), a meeting of the Board of Directors of the company is scheduled to be held on Thursday,2gth octob er,2026,inter alia, To consider and approve the Unaudited Financial Results of the Company for the Quarter and Half Year ended on September 30, 2026. Any other business with permission of Chair, if any. Further, in continuation to our intimation dated September 29,2026 we would 1ike to inform that as per the Company's Code of Conduct for privention of Insider Trading, framed under the Securities and Exchange Board of India (Prohibition of Insider Tradin!) Regulations, 2015, the Trading Window for dealing in the equity shares of the Company has already been closed from October 01, 2026, and the same will remain closed tiil 4g hours after the communication of the aforesaid financial results to the Stock Exchange. We request you to kindly take the above on record and bring to the notice of all concemed. Thanking You, Yours Faithfully For Colinz Laboratories Ltd. L,4UMBAl Vijaya Mani Director Din No. 11363910 Laboratories Limited CIN NO- L242001\4Hl 986pLC041 I 28 Corp.Off.:A/l0l,PratikEstate,NexttoFortisHospital,MuiundLinkRoad,P.BoxNo. 17339Mumbai-40007g tND|A E-mail : colinzlabs@yahoo.com / colinzlabs@gmail.com Mobile .9137392123